News

Filter

Current filters:

PfizerGlaxoSmithKline

1 to 9 of 556 results

MSF calls on GSK and Pfizer to slash pneumo vaccine price to $5

MSF calls on GSK and Pfizer to slash pneumo vaccine price to $5

20-01-2015

Médecins Sans Frontières (MSF) has called on UK pharma major GlaxoSmithKline and US pharma giant Pfizer…

GlaxoSmithKlineMSFPfizerPharmaceuticalPricingRest of the WorldVaccinationVaccines

World’s largest collection of deprioritized pharma compounds opens to researchers

World’s largest collection of deprioritized pharma compounds opens to researchers

09-12-2014

A collection of 68 deprioritized pharmaceutical compounds is being made available to academic researchers…

AstraZenecaEli LillyGlaxoSmithKlineJanssen Research & DevelopmentPfizerPharmaceuticalResearchTakeda PharmaceuticalUCBUK

Pfizer looks set to win $100 million Russian vaccines contract

16-10-2014

The Swiss unit of US pharma giant Pfizer has remained the only bidder for the 3.47 billion-rouble ($100…

GlaxoSmithKlineMarkets & MarketingPfizerPharmaceuticalPrevenarRussiaSynflorixVaccines

Pfizer and GSK to compete for $120 million Russian pneumococcal vaccine contract

Pfizer and GSK to compete for $120 million Russian pneumococcal vaccine contract

08-10-2014

US pharma giant Pfizer and UK peer GlaxoSmithKline plan to compete for the 3.47 billion-rouble ($120…

GlaxoSmithKlineMarkets & MarketingPfizerPharmaceuticalPrevenarRussiaSynflorixVaccines

MMIP formally established to boost medicines manufacturing in the UK

23-09-2014

A new Medicines Manufacturing Industry Partnership (MMIP) has been jointly established by the Association…

ActavisEisaiFujifilm Diosynth BiotechnologiesGlaxoSmithKlineOxford BioMedicaPfizerPharmaceuticalProductionUK

ViiV Healthcare gains FDA approval for HIV drug Triumeq

ViiV Healthcare gains FDA approval for HIV drug Triumeq

23-08-2014

The US Food and Drug Administration has approved Triumeq (abacavir 600mg, dolutegravir 50mg and lamivudine…

Anti-viralsGlaxoSmithKlinePfizerPharmaceuticalRegulationShionogiTriumeqUSAViiV Healthcare

Seven pharma companies offer up compounds to UK researchers

Seven pharma companies offer up compounds to UK researchers

22-07-2014

UK researchers will be granted access to a ‘virtual library’ of deprioritized pharmaceutical compounds…

AstraZenecaEli LillyGlaxoSmithKlineJanssenMedical Research CouncilPfizerPharmaceuticalResearchTakeda PharmaceuticalUCBUK

1 to 9 of 556 results

Back to top